We previously demonstrated that CD26/DPP4 inhibition by sitagliptin ameliorated lipopolysaccharide (LPS)-induced lung injury in mice through its anti-inflammatory effects on pulmonary endothelial cells, indicating a relationship between pulmonary endothelium in ARDS and CD26/DPP4 [17]. Here, DPP4 is linked to acute respiratory distress syndrome.